Genetic and environmental influences on sensory gating of mid-latency auditory evoked responses: A twin study

被引:65
作者
Anokhin, Andrey P. [1 ]
Vedeniapin, Andrei B.
Heath, Andrew C.
Korzyukov, Oleg
Boutros, Nashaat N.
机构
[1] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA
[2] Wayne State Univ, Sch Med, Dept Psychiat & Behav Neurosci, Detroit, MI USA
关键词
auditory evoked potentials; P50; N100; sensory gating; twins; heritability; P50; SUPPRESSION; NO EVIDENCE; SCHIZOPHRENIA; RELIABILITY; DEFICITS; POTENTIALS; COMPONENTS; AMPLITUDE; LINKAGE;
D O I
10.1016/j.schres.2006.08.009
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
A deficit in sensory gating measured by the suppression of P50 auditory event-related potential (ERP) has been implicated in the biological bases of schizophrenia and some other psychiatric disorders and proposed as a candidate endophenotype for genetic studies. More recently, it has been shown that gating deficits in schizophrenics extend to ERP components reflecting early attentive processing (the N1/P2 complex). However, evidence for heritability of sensory gating in the general population is very limited. Heritability of P50, N1, and P2 amplitudes and gating was estimated in 54 monozygotic and 55 dizygotic twin pairs using a dual-click auditory paradigm. Genetic model-fitting analysis showed high heritability of peak amplitudes of P50, N1, and P2 waves. Genetic influences on P50 gating (S2/S1) were modest, while heritability of NI and P2 gating was high and significant. The alternative gating measure (S1-S2 difference) showed significant heritability for all three ERP components. Weak genetic influences on P50 gating ratio can be related to its poor test-retest reliability demonstrated in previous studies. These results suggest that gating measures derived from the N1/P2 wave complex may be useful endophenotypes for population-based genetic studies of the sensory gating function and its impairments in psychopathology. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:312 / 319
页数:8
相关论文
共 43 条
  • [1] Elementary phenotypes in the neurobiological and genetic study of schizophrenia
    Adler, LE
    Freedman, R
    Ross, RG
    Olincy, A
    Waldo, MC
    [J]. BIOLOGICAL PSYCHIATRY, 1999, 46 (01) : 8 - 18
  • [2] Normal P50 gating in unmedicated schizophrenia outpatients
    Arnfred, SM
    Chen, ACN
    Glenthoj, BY
    Hemmingsen, RP
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (12) : 2236 - 2238
  • [3] Response to the first stimulus determines reduced auditory evoked response suppression in schizophrenia: single trials analysis using MEG
    Blumenfeld, LD
    Clementz, BA
    [J]. CLINICAL NEUROPHYSIOLOGY, 2001, 112 (09) : 1650 - 1659
  • [4] Comparison of four components of sensory gating in schizophrenia and normal subjects: a preliminary report
    Boutros, NN
    Belger, A
    Campbell, D
    D'Souza, C
    Krystal, J
    [J]. PSYCHIATRY RESEARCH, 1999, 88 (02) : 119 - 130
  • [5] Sensory gating deficits during the mid-latency phase of information processing in medicated schizophrenia patients
    Boutros, NN
    Korzyukov, O
    Jansen, B
    Feingold, A
    Bell, M
    [J]. PSYCHIATRY RESEARCH, 2004, 126 (03) : 203 - 215
  • [6] Morphological and latency abnormalities of the mid-latency auditory evoked responses in schizophrenia: a preliminary report
    Boutros, NN
    Korzyuko, O
    Oliwa, G
    Feingold, A
    Campbell, D
    McClain-Furmanski, D
    Struve, F
    Jansen, BH
    [J]. SCHIZOPHRENIA RESEARCH, 2004, 70 (2-3) : 303 - 313
  • [7] TEST-RETEST RELIABILITY OF THE P50 MIDLATENCY AUDITORY EVOKED-RESPONSE
    BOUTROS, NN
    OVERALL, J
    ZOURIDAKIS, G
    [J]. PSYCHIATRY RESEARCH, 1991, 39 (02) : 181 - 192
  • [8] Midlatency evoked potentials attenuation and augmentation reflect different aspects of sensory gating
    Boutros, NN
    Belger, A
    [J]. BIOLOGICAL PSYCHIATRY, 1999, 45 (07) : 917 - 922
  • [9] BRAFF DL, 1990, ARCH GEN PSYCHIAT, V47, P181
  • [10] Preattentional and attentional cognitive deficits as targets for treating schizophrenia
    Braff, DL
    Light, GA
    [J]. PSYCHOPHARMACOLOGY, 2004, 174 (01) : 75 - 85